[CytoReason in The Times of Israel] Sanofi extends cooperation with Israel’s CytoReason for bowel disease drug discovery

[CytoReason in The Times of Israel] Sanofi extends cooperation with Israel’s CytoReason for bowel disease drug discovery

Source Node: 1919357

Tel Aviv-based startup that uses AI to build digital models of the human immune system and diseases inks multi-million-dollar deal with French drugmaker

Read more here.

Time Stamp:

More from OurCrowd Blog